Customer Area

MosaiQ
LumiQ
Alba
Scientific Insights Center
About Us
News & Media
Contact Us

Get In Touch

Request an Alba consult
MosaiQ Inquiry

Search

Press “Enter” or click on the search icon to show results.

Scientific Insights Center

Explore a collection of abstracts, blogs, publications and video demonstrations. Gain insights that deepen scientific understanding and receive updates about our autoimmune and allergy solutions.

Scientific Communications

Webinars

Blogs

Categories

Scientific Communications Webinars Blogs

Filters

Allergy Autoimmune Celiac Disease Connective Tissue Disease IFA LumiQ MosaiQ

Scientific Communications

Analytical Performance of a Novel, Fully Automated Multiplexed Microarray Immunoassay for the Simultaneous Detection of Anti-PR3, Anti-MPO, and Anti-GBM Autoantibodies

Autoimmune

Clinical Performance of a Novel, Fully Automated Multiplexed Immunoassay for the Simultaneous Detection of Anti-PR3, Anti-MPO, and Anti-GBM Autoantibodies in ANCA-Associated Vasculitis and Anti-GBM Disease

Autoimmune

Machine learning classification based on a 15-autoantibody profile by a fully automated multiplex microarray immunoassay for autoimmune CTD diagnosis

Autoimmune Connective Tissue Disease LumiQ MosaiQ

Analytical Performance of a Novel Automated Immunoassay Microarray analyzing simultaneously 5 markers associated with Celiac Disease. ACG2024.

Autoimmune Celiac Disease

Performance characteristics of Automated Immunoassay Microarray prototype detecting Centromere Protein B (CENP-B). AACC2023.

Autoimmune Connective Tissue Disease

Performance characteristics of Automated Immunoassay Microarray detecting Anti-Centromere Protein B antibodies. Immunochemistry & Immunopathology 2023.

Autoimmune Connective Tissue Disease

Performance characteristics of Automated Immunoassay Microarray prototype analyzing simultaneously 11 IgG markers associated with Connective Tissue Diseases. ACR2023.

Autoimmune Connective Tissue Disease

Analytical Performance of a Novel Automated Immunoassay Microarray analyzing simultaneously 15 markers associated with Connective Tissue Diseases. IFCC2024.

Autoimmune Connective Tissue Disease

Analytical Evaluation of Automated Immunoassay Microarray analyzing simultaneously 11 markers associated with Connective Tissue Diseases in a Spanish Reference Laboratory. ADLM2024.

Autoimmune Connective Tissue Disease

Automated Immunoassay Microarray for Detecting Bet v 1-Specific IgE: Performance & Findings from ECI 2024

Allergy

Webinars

LumiQ® System Demonstration

LumiQ

MosaiQ® System Demonstration

MosaiQ

Advances in the Serological Evaluation of Celiac Disease

Celiac Disease

Blogs

Vasculitis Diagnosis: Microarray Testing with MosaiQ AiPlex® VAS

Autoimmune MosaiQ

Multiplex Microarray Testing for Connective Tissue Diseases

Connective Tissue Disease MosaiQ

Celiac Disease Diagnostics and the Future of Autoimmune Testing

Autoimmune Celiac Disease

Diabetes Diagnostics: The Need for Advanced Autoimmune Testing

Autoimmune

Unlock Lab Efficiencies with an AliveDx Evaluation

LumiQ MosaiQ

Multiplexing: Streamline Autoimmune Testing with MosaiQ AiPlex® CTDplus

Connective Tissue Disease MosaiQ

How Machine Learning Is Transforming CTD Diagnosis

Connective Tissue Disease MosaiQ

Transforming Vasculitis Diagnostics: Multiplex Microarray Solutions for PR3, MPO & GBM Autoantibodies

Autoimmune MosaiQ

Unlocking Comprehensive Insights in Autoimmune Diagnostics: The Role of Anti-DFS70 Autoantibodies

Autoimmune Connective Tissue Disease

Learn more about our solutions

Discover how our solutions can help optimize your lab’s workflow for improved efficiency.

Latest News

Our passion for the work we do is matched only by our commitment to consistently provide the best customer experience possible.

February 16, 2026

AliveDx Suisse S.A. and Ilex Medical Sign Strategic Distribution Agreement in Israel

AliveDx Suisse S.A. is pleased to announce the signing of a strategic distribution agreement with Ilex Medical. Under this agreement, Ilex Medical is authorized to distribute AliveDx’s MosaiQ® and LumiQ® solutions in Israel. This partnership represents another important milestone in
February 12, 2026

AliveDx Suisse S.A. and Hospital Supply Corporation (HSC) Sign Strategic Distribution Agreement in Pakistan

AliveDx Suisse S.A. is pleased to announce the signing of a strategic distribution agreement with Hospital Supply Corporation (HSC), Pakistan. Under this agreement, HSC is authorized to distribute AliveDx’s MosaiQ® and LumiQ® solutions across Pakistan. This partnership represents an important milestone in AliveDx’s expansion in South Asia and
February 12, 2026

AliveDx Suisse S.A. and Reacting Sarl Sign Strategic Distribution Agreement in Morocco

AliveDx Suisse S.A. is pleased to announce the signing of a strategic distribution agreement with Reacting Sarl. Under this agreement, Reacting Sarl is authorized to distribute AliveDx’s MosaiQ® and LumiQ® solutions across Morocco. This partnership represents a further step in
February 11, 2026

AliveDx Suisse S.A. and Address Medical Sign Strategic Distribution Agreement in United Arab Emirates

AliveDx Suisse S.A. is pleased to announce the signing of a strategic distribution agreement with Address Medical. Under this agreement, Address Medical is authorized to distribute AliveDx’s MosaiQ® and LumiQ® solutions in United Arab Emirates. This partnership represents another important
February 10, 2026

AliveDx & DPC Lebanon: Distribution Agreement Announcement

AliveDx Suisse S.A. and DPC Lebanon (Diagnostic Products Corporation Lebanon Sarl) Sign Strategic Distribution Agreement in Lebanon AliveDx Suisse S.A. is pleased to announce the signing of a strategic distribution agreement with DPC Lebanon. Under this agreement, DPC Lebanon is
December 2, 2025

AliveDx Achieves NHS UK Evergreen Level 2 in Annual Sustainability Assessment

AliveDx is proud to announce that we have successfully completed the 2025/26 NHS Evergreen Sustainable Supplier Assessment, achieving Level 2 status in the UK. This annual assessment is a key benchmark for suppliers to the NHS in the UK, measuring

Fill in the form to get access to the resource

First name(Required)

Last name(Required)

Job Title(Required)

Company(Required)

Email(Required)

Country(Required)

State(Required)

Please indicate your interest in(Required)

MosaiQ

LumiQ

Autoimmune Disease

Celiac Disease

Connective Tissue Disease

Allergy

Privacy Policy(Required)

By registering to receive information about MosaiQ, I consent to AliveDx’s Privacy policy.

Communications

I consent to my email address being registered to receive AliveDx product-related communication.

Copyright © 2025 AliveDx

Legal Notice. Privacy Policy.
Data Protection Officer.

Solutions

MosaiQ®

LumiQ®

Alba

About Us

Who We Are

Investors

Our Leadership Team

Our Board of Directors

Code of Business Conduct & Ethics

News & Media

News

Press Releases

Media Kit

Scientific Insights Center

Contact Us

Request an Alba consult

MosaiQ & LumiQ Inquiry

Company Insights

Careers

Available Positions

Life at AliveDx

Gender Pay Report

ESG Commitments

Manage Consent

To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Manage options
Manage services
Manage {vendor_count} vendors
Read more about these purposes

View preferences

{title}
{title}
{title}

Manage Consent

To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Manage options
Manage services
Manage {vendor_count} vendors
Read more about these purposes

View preferences

{title}
{title}
{title}